A PET (positron emission tomography) study using 89Zr-Df-IAB2M for glioma
Phase 1
- Conditions
- Glioma
- Registration Number
- JPRN-UMIN000018639
- Lead Sponsor
- niversity of Tsukuba
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patients without operative indication (2) Patients with severe cardiovascular, respiratory, renal, gastrointestinal, hematological, or neuropsychiatric disease (3) Patients whose doctors determined as inadequate for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety: Adverse events within the 2 days after intervention
- Secondary Outcome Measures
Name Time Method 1) Imaging of tumor neovasculature 2) PET imaging condition